Acquisition of Multidrug‐ResistantPseudomonas aeruginosain Patients in Intensive Care Units: Role of Antibiotics with Antipseudomonal Activity

This publication has 36 references indexed in Scilit:

• Risk Factors for Piperacillin-Tazobactam-Resistant Pseudomonas aeruginosa among Hospitalized Patients
  Antimicrobial Agents and Chemotherapy, 2002
• Risk Factors for Imipenem-Resistant Pseudomonas aeruginosa among Hospitalized Patients
  Clinical Infectious Diseases, 2002
• National Nosocomial Infections Surveillance (NNIS) System Report, Data Summary from January 1992-June 2001, Issued August 2001
  American Journal of Infection Control, 2001
• Characterization ofPseudomonas aeruginosaIsolates: Occurrence Rates, Antimicrobial Susceptibility Patterns, and Molecular Typing in the Global SENTRY Antimicrobial Surveillance Program, 1997–1999
  Clinical Infectious Diseases, 2001
• Microbial resistance: lessons from the EPIC study
  Intensive Care Medicine, 2000
• Surveillance of Antimicrobial Use and Antimicrobial Resistance in United States Hospitals: Project ICARE Phase 2
  Clinical Infectious Diseases, 1999
• Nosocomial Infections With Ceftazidime-Resistant Pseudomonas aeruginosa: Risk Factors and Outcome
  Infection Control & Hospital Epidemiology, 1999
• Consequences of Bacterial Resistance to Antibiotics in Medical Practice
  Clinical Infectious Diseases, 1997
• Predominant pathogens found in the European prevalence of infection in intensive care study
  European Journal of Clinical Microbiology & Infectious Diseases, 1996
• Strategies to Prevent and Control the Emergence and Spread of Antimicrobial-Resistant Microorganisms in Hospitals. A challenge to hospital leadership
  Published by American Medical Association (AMA) ,1996